Patient-Reported Outcomes/Metrics Program Trial - Palliative Radiation
What is the PROMPT Study?
The PROMPT Study is a 1-year clinical trial that will monitor the Quality of Life (QoL) of 100 patients that are undergoing radiotherapy. Principal Investigators, Dr. Aisling Barry and Dr. Philip Wong from Princess Margaret Cancer Centre, are using Zamplo to monitor QoL and toxicity monitoring in a clinical trial known as PROMPT - Palliative Radiation.
Hexoskin is a wearable smart shirt that has been used to monitor astronauts' physiology around the clock as they orbit the planet. In the PROMPT study, cancer patients scheduled for radiation therapy will be wearing the Hexoskin shirt to record their health data and will use Zamplo to monitor their symptoms. Patients will be able to see a daily summary of their Hexoskin data in Zamplo.
How is Zamplo being used?
In the PROMPT study, cancer patients scheduled for radiation therapy will be using Zamplo to monitor their symptoms and see a daily summary of their health data.
Those involved in PROMPT will use Zamplo to:
Meet the Team
Dr. Philip Wong
Dr. Philip Wong is a Radiation Oncologist at the Princess Margaret Cancer Centre. His interests include novel technologies in the care of cancer patients and the evaluation of patient-facing applications and biometric tools for the monitoring of patients undergoing treatments.
Dr. Aisling Barry
Dr. Aisling Barry is a Radiation Oncologist and consultant at Princess Margaret Cancer Center in Toronto. Her research interests include primary and secondary liver cancer, and palliative radiotherapy, among others.